Ramucirumab and durvalumab for previously treated, advanced non–small-cell lung cancer, gastric/gastro-oesophageal junction adenocarcinoma, or hepatocellular carcinoma: An open-label, phase Ia/b study (JVDJ)
Titel:
Ramucirumab and durvalumab for previously treated, advanced non–small-cell lung cancer, gastric/gastro-oesophageal junction adenocarcinoma, or hepatocellular carcinoma: An open-label, phase Ia/b study (JVDJ)
Auteur:
Bang, Yung-Jue Golan, Talia Dahan, Laetitia Fu, Siqing Moreno, Victor Park, Keunchil Geva, Ravit De Braud, Filippo Wainberg, Zev A. Reck, Martin Goff, Laura Laing, Naomi Mi, Gu Oliveira, Joana M. Wasserstrom, Heather Lin, Chia-Chi